Key takeaways<\/h2>\n\n- \n
Incruse Ellipta and Spiriva are both brand-name, FDA-approved anticholinergic medications used for the long-term maintenance treatment of COPD, but they have some differences.<\/span><\/p>\n<\/li>\n- \n
Incruse Ellipta is more effective than Spiriva in a 12-week study comparing their efficacy and safety in patients with COPD, though both drugs showed meaningful improvements in quality of life.<\/span><\/p>\n<\/li>\n- \n
Both medications are typically covered by insurance and Medicare Part D, with the out-of-pocket price potentially reduced by using a card or coupon.<\/span><\/p>\n<\/li>\n- \n
Common side effects of both drugs include respiratory infections and cough, with Spiriva also commonly causing sinusitis, chest pain, dry mouth, and urinary tract infection, among others.<\/span><\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\n\n\n
\n\t\t\t\t\t\t\t\t![](\"https:\/\/www.singlecare.com\/blog\/wp-content\/themes\/singlecare\/images\/union.svg\")
<\/span>
\n\t\t\t\t\t\t\t
Incruse Ellipta and Spiriva are both brand-name, FDA-approved anticholinergic medications used for the long-term maintenance treatment of COPD, but they have some differences.<\/span><\/p>\n<\/li>\n Incruse Ellipta is more effective than Spiriva in a 12-week study comparing their efficacy and safety in patients with COPD, though both drugs showed meaningful improvements in quality of life.<\/span><\/p>\n<\/li>\n Both medications are typically covered by insurance and Medicare Part D, with the out-of-pocket price potentially reduced by using a card or coupon.<\/span><\/p>\n<\/li>\n Common side effects of both drugs include respiratory infections and cough, with Spiriva also commonly causing sinusitis, chest pain, dry mouth, and urinary tract infection, among others.<\/span><\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n
\n\t\t\t\t\t\t\t\t<\/span>
\n\t\t\t\t\t\t\t